Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema

International Journal of Dermatology

Volumn 50, Issue 12, 2011, Pages 1486-1490

  Magin, Parker J ^a   Pond, C Dimity ^a   Smith, Wayne T ^a   Watson, Alan B ^b   Goode, Susan M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Royal Newcastle Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADULT; ANXIETY; ARTICLE; ATOPIC DERMATITIS; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LEEDS TECHNIQUE; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSYCHOLOGICAL ASPECT; SELF EVALUATION; SIX AREA SIX SIGN ATOPIC DERMATITIS;

ACNE VULGARIS; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DERMATITIS, ATOPIC; HUMANS; PSORIASIS; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 81855173302     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.04883.x     Document Type: Article

References (42)

1. Sampogna F, Sera F, Abeni D, Investigators IDIMPRoVE. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004; 122: 602-607.
2. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989; 14: 194-198.
3. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273-282.
4. Magin P, Adams J, Heading G, et al. Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Physician 2006; 52: 978-979.
5. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004; 45: 155-159.
6. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-54.
7. Sampogna F, Picardi A, Melchi CF, et al. The impact of skin diseases on patients: comparing dermatologists' opinions with research data collected on their patients. Br J Dermatol 2003; 148: 989-995.
8. Poot F, Janne P, Tordeurs D, et al. Psychosomatics and dermatology: comparison between objective data and subjective imprressions given by patients and dermatologists. Dermatol Psychosom 2001; 1: 19-25.
9. Magin P, Adams J, Heading G, Pond D. Patients with skin disease and their relationship with their doctors: results of a qualitative study of acne, psoriasis and eczema. Med J Aust 2009; 190: 62-64.
10. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol 1988; 18: 325-333.
11. Mosam A, Vawda NB, Gordhan AH, et al. Quality of life issues for South Africans with acne vulgaris. Clin Exp Dermatol 2005; 30: 6-9.
12. Jenner N, Campbell J, Marks R. Morbidity and cost of atopic eczema in Australia. Australas J Dermatol 2004; 45: 16-22.
13. Kupfer J, Niemeier V, Brosig B, et al. Sense of coherence among psoriatics as a predictor of symptom-free time following dermatological inpatient therapy. Dermatol Psychosom 2003; 4: 200-206.
14. Hanstock TL, O'Mahony JF. Perfectionism, acne and appearance concerns. Pers Individ Diff 2002; 32: 1317-1325.
15. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol 2001; 145: 274-279.
16. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CEM. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997; 42: 467-475.
17. Hanstock TL, O'Mahony JF. Treatment seeking in young women with acne. Dermatol Psychosom 2003; 4: 194-199.
18. Feldman SR, Fleischer AB Jr, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106: 183-186.
19. Jenner N, Campbell J, Plunkett A, Marks R. Cost of psoriasis: a study of the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol 2002; 43: 255-261.
20. Gutgesell C, Heise S, Seubert A, et al. Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores. Br J Dermatol 2002; 147: 914-919.
21. Sackett DL, Haynes RB, Guyett GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd edn. Boston: Little Brown, 1991.
22. Magin PJ, Pond CD, Smith WT, et al. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatol Venereol 2008; 22: 1435-1444.
23. Burke BM, Cunliffe WJ. The assessment of acne vulgaris - the leeds technique. Br J Dermatol 1984; 111: 83-92.
24. Langley RG, Ellis CN. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 2004; 51: 563-569.
25. Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135(Suppl 48): 25-30.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
27. Bowling A. Measuring Disease. Buckingham: Open University Press, 1995.
28. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res 2002; 52: 69-77.
29. Lewis G, Wessely S. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale. Br J Psychiatry 1990; 157: 860-864.
30. Martin CR, Tweed AE, Metcalfe MS. A psychometric evaluation of the Hospital Anxiety and Depression Scale in patients diagnosed with end-stage renal disease. Br J Clin Psychol 2004; 43: 51-64.
31. Folks DG. Screening for psychiatric disorders in patients with skin diseases. J Psychosom Res 2004; 57: 225-226.
32. Fenigstein A, Scheier MF, Buss AH. Public and private self-consciousness: assessment and theory. J Consult Clin Psychol 1975; 43: 522-527.
33. Ben-Artzi E. Factor structure of the private self-consciousness scale: role of item wording. J Pers Assess 2003; 81: 256-264.
34. Scheier MF, Carver CS. The self-consciousnesss scale: a revised version for use in general populations. J Appl Soc Psychol 1985; 15: 687-699.
35. Magin P, Adams J, Heading G, et al. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med 2009; 14: 150-161.
36. Duncan-Jones P. Short Stable Measures of Extraversion and Neuroticism for Australian General Population. Canberra: Australian National University, 1983.
37. Ahmar H, Kurban AK. Psychological profile of patients with atopic dermatitis. Br J Dermatol 1976; 95: 373-377.
38. Lim CC, Tan TC. Personality, disability and acne in college students. Clin Exp Dermatol 1991; 16: 371-373.
39. Jordan JM, Whitlock FA. Emotions and the skin: the conditioning of scratch responses in cases of atopic dermatitis. Br J Dermatol 1972; 86: 574-585.
40. Pagano M, Gauvreau K. Principles of Biostatistics, 2nd edn. Pacific Grove: Duxbury, 2000.
41. Jemec GB, Wulf HC. Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol 1996; 21: 177-179.
42. Haverstock CL, Feldman SR. Prescribing on the basis of subjective disease severity. J Dermatolog Treat 2006; 17: 261.